It was reported in a literature article by akoh et.Al.In an article titled, "adverse events involving hallux metatarsophalangeal joint implants: comprehensive analysis of us food and drug administration data from 2010 to 2018" the author did a review of the us food and drug administration's (fda) manufacturer and user facility device experience (maude) database from 2010-2018 to determine reported adverse events for hallux mtpj arthroplasty.Among 64 unique hallux mtpj implant adverse events, the most common modes of failure were component loosening (34%), component fracture (9.4%), inflammation (9.4%), infection (14.1%), and allergic reaction (7.8%).In regards to implant type, synthetic implants (cartiva) had the highest percentage of adverse events (23.4%), followed by arthrosurface toemotion (20.3%), ascension mgt (12.5%), arthrosurface hemicap (10.9%), futura primus (9.4%), and osteomed reflexion (6.3%).
|